EU agency levies fines in drug patent settlement cases

06/3/2013 | Reuters

Lundbeck, Merck KGaA and Ranbaxy are among the drugmakers fined by the European Commission for allegedly striking patent settlement deals to keep generic drugs off the market. Generics UK, Arrow, Resolution Chemicals, A.L. Industrier, Xellia Pharmaceuticals and Alpharma will also be fined.

View Full Article in: